Direxion Daily Biotech Top 5 Bull 2X ETF
- ETF
- Ticker TBXU
- NYSE
Performance, volatility and drawdowns of Direxion Daily Biotech Top 5 Bull 2X ETF since 10/2025, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $15,754. Global equities (VT): $10,273.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −26.5% in 06/2026, measured from the peak in 02/2026. It took 6 months to get back to the old peak.
Annual returns
* partial year.
Similar ETFs
Frequently asked questions
How has TBXU performed since 10/2025?
$10,000 grew to $17,019 by 20 Nov 2026, which is +59.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is TBXU?
Volatility was 40.4% per year, measured on monthly returns. The largest decline from a peak was −26.5%, with the low in 06/2026.
How does TBXU compare with a broad equity ETF?
Over the same period Global equities (VT) returned +3.8% per year at 15.7% volatility, TBXU returned +59.7% at 40.4%. The correlation of monthly returns was 0.22; 1 would mean they moved in lockstep.
What does TBXU hold?
TBXU holds 5 positions. The largest are Regeneron Pharmaceuticals, Inc. COM USD0.001, Amgen Inc. COM USD0.0001 and Vertex Pharmaceuticals Incorporated COM USD0.01; the 5 largest together make up 39.4% of the fund (holdings as of 31 Jul 2026, according to the fund's filing with the SEC).
Which currency are the figures in?
In US dollars, the currency of the US listing.